Rezolute, Inc. (RZLT)

Rezolute, Inc. (RZLT) is a healthcare company (biotechnology) based in the United States. The share price is $3.78, up 5.59% on the day, which values the company at $448.95M. Price as of 17 Nov 2026, 17:37 UTC, from Yahoo Finance.

Key facts

Share price
$3.78+5.59% today
Market value
$448.95M
200-week average
$3.722% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Rezolute, Inc. in more detail

RZLT trades at -7.9× next year's expected earnings. It sits 2% above its 200-week average of $3.72.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold RZLT, including Peter Kolchinsky (0.4% of the portfolio).

Superinvestors holding RZLT

1 of the investors tracked here report a position in their latest 13F filing.

Rezolute, Inc. (RZLT): questions and answers

What is Rezolute, Inc.'s market cap?

Rezolute, Inc. is valued at $448.95M at a share price of $3.78.

Is RZLT above its 200-week moving average?

Yes. RZLT is 1.6% above its 200-week average of $3.72. Long-term investors watch that line because strong companies rarely trade below it for long.

Does RZLT pay a dividend?

Rezolute, Inc. does not currently pay a regular dividend.

Which famous investors own RZLT?

In their latest quarterly filings, Peter Kolchinsky (0.4% of the portfolio) hold RZLT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Rezolute, Inc. (RZLT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RZLT

Underlying data: Yahoo Finance; company filings with the SEC.